Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets

by Barratt-Due, Andreas, Pischke, Søren Erik, Nilsson, Per H., Espevik, Terje, Mollnes, Tom Eirik
Published 2017

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome

by Barratt-Due, Andreas, Fløisand, Yngvar, Orrem, Hilde L., Kvam, Ann K., Holme, Pål A., Bergseth, Grethe, Tjønnfjord, Geir E., Mollnes, Tom E.
Published 2016

Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis

by Skjeflo, Espen W., Sagatun, Caroline, Dybwik, Knut, Aam, Sturla, Urving, Sven H., Nunn, Miles A., Fure, Hilde, Lau, Corinna, Brekke, Ole-Lars, Huber-Lang, Markus, Espevik, Terje, Barratt-Due, Andreas, Nielsen, Erik W., Mollnes, Tom E.
Published 2015